title: Commentary.
authors: National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD. andrew.mammen@nih.gov.
authors: Andrew
authors: A
authors: Mammen
mesh_terms: D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000276:immunology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009132:Muscles / Q000187:drug effects / Q000473:pathology; D009135:Muscular Diseases / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy* / Q000276:immunology
chemical_list: D001323:Autoantibodies; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D006903:Hydroxymethylglutaryl CoA Reductases